1. Home
  2. TALKW vs RVPHW Comparison

TALKW vs RVPHW Comparison

Compare TALKW & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TALKW
  • RVPHW
  • Stock Information
  • Founded
  • TALKW 2012
  • RVPHW 2018
  • Country
  • TALKW United States
  • RVPHW United States
  • Employees
  • TALKW 521
  • RVPHW 14
  • Industry
  • TALKW Medical/Nursing Services
  • RVPHW Biotechnology: Pharmaceutical Preparations
  • Sector
  • TALKW Health Care
  • RVPHW Health Care
  • Exchange
  • TALKW Nasdaq
  • RVPHW Nasdaq
  • Market Cap
  • TALKW N/A
  • RVPHW N/A
  • IPO Year
  • TALKW N/A
  • RVPHW N/A
  • Fundamental
  • Price
  • TALKW $0.08
  • RVPHW $0.05
  • Analyst Decision
  • TALKW
  • RVPHW
  • Analyst Count
  • TALKW 0
  • RVPHW 0
  • Target Price
  • TALKW N/A
  • RVPHW N/A
  • AVG Volume (30 Days)
  • TALKW 64.2K
  • RVPHW 22.4K
  • Earning Date
  • TALKW 02-20-2025
  • RVPHW 03-14-2025
  • Dividend Yield
  • TALKW N/A
  • RVPHW N/A
  • EPS Growth
  • TALKW N/A
  • RVPHW N/A
  • EPS
  • TALKW N/A
  • RVPHW N/A
  • Revenue
  • TALKW $181,291,000.00
  • RVPHW N/A
  • Revenue This Year
  • TALKW N/A
  • RVPHW N/A
  • Revenue Next Year
  • TALKW N/A
  • RVPHW N/A
  • P/E Ratio
  • TALKW N/A
  • RVPHW N/A
  • Revenue Growth
  • TALKW 31.50
  • RVPHW N/A
  • 52 Week Low
  • TALKW $0.20
  • RVPHW $0.13
  • 52 Week High
  • TALKW $0.24
  • RVPHW $0.15
  • Technical
  • Relative Strength Index (RSI)
  • TALKW N/A
  • RVPHW N/A
  • Support Level
  • TALKW N/A
  • RVPHW N/A
  • Resistance Level
  • TALKW N/A
  • RVPHW N/A
  • Average True Range (ATR)
  • TALKW 0.00
  • RVPHW 0.00
  • MACD
  • TALKW 0.00
  • RVPHW 0.00
  • Stochastic Oscillator
  • TALKW 0.00
  • RVPHW 0.00

About TALKW Talkspace Inc. Warrant

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.

About RVPHW Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: